WINTON GROUP Ltd

Position in FTRE — Fortrea Holdings Inc.

CIK 1612063 LONDON, X0

Position in FTRE

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$2,892,844

-$1,927,789 QoQ

Shares Held

307,096

+9.9% QoQ

Ownership

0.325%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

WINTON GROUP Ltd holds $82,857,367 across 70 Biotechnology names. FTRE ranks #7 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	173,032	$16,285,771
2	REGN	Regeneron Pharmaceuticals, Inc.	14,778	$11,418,073
3	IONS	Ionis Pharmaceuticals Inc	106,532	$7,999,487
4	BBIO	BridgeBio Pharma, Inc.	47,925	$3,558,910
5	ARWR	Arrowhead Pharmaceuticals, Inc.	55,080	$3,453,516
6	VIR	Vir Biotechnology, Inc.	367,883	$3,296,231
7	FTRE	Fortrea Holdings Inc. This page	307,096	$2,892,844
8	APLS	Apellis Pharmaceuticals, Inc.	69,291	$2,787,576

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,892,844	307,096	+9.9%	Shares	Sole	2026-05-12
2025-12-31	$4,820,633	279,457	-8.3%	Shares	Sole	2026-02-11
2025-09-30	$2,565,355	304,674	+2830.1%	Shares	Sole	2025-11-13
2025-06-30	$51,366	10,398	-92.0%	Shares	Sole	2025-08-14
2025-03-31	$980,382	129,852	+113.6%	Shares	Sole	2025-05-15
2024-12-31	$1,133,882	60,798	+112.3%	Shares	Sole	2025-02-12
2024-03-31	$1,149,489	28,637	+93.6%	Shares	Sole	2024-05-14
2023-12-31	$516,136	14,789	+0.1%	Shares	Sole	2024-02-12
2023-09-30	$422,245	14,769	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.